Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Bone diseases

Quality of life

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

21-06-2018 | Osteoporosis | Article

Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys

Yoshimura N et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4596-4

12-06-2018 | Osteoporosis | Article

Characteristics of recurrent fractures

Kanis JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4502-0

14-05-2018 | Osteoporosis | Article

Prevalence and comorbidity of osteoporosis: A cross-sectional analysis on 10,660 adults aged 50 years and older in Germany

Puth MT et al. BMC Musculoskelet Disord 2018; 19: 144. doi: 10.1186/s12891-018-2060-4

02-05-2018 | Osteoporosis | Review | Article

Novel imaging modalities in osteoporosis diagnosis and risk stratification

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

30-04-2018 | Osteoarthritis | Article

Effects of glucosamine in patients with osteoarthritis of the knee: A systematic review and meta-analysis

Ogata T et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4106-2

07-03-2017 | Osteoporosis | Review | Article

Pediatric osteoporosis: Diagnosis and treatment considerations

Osteoporosis is increasingly recognized in children due to the increased prevalence of disorders associated with bone loss. This review explores diagnosis and treatment considerations in this population.

Marrani E et al. Drugs 2017;77:679–695. doi:10.1007/s40265-017-0715-3

19-12-2016 | Paget's disease | Review | Article

Clinical and genetic advances in Paget’s disease of bone: A review

Alonso N, Calero-Paniagua I, del Pino-Montes J. Clinic Rev Bone Miner Metab 2017; 15: 37. doi: 10.1007/s12018-016-9226-0

28-04-2016 | Osteoporosis | Review | Article

The management of osteoporosis in children

An expert review of the manifestations of osteoporosis in childhood, recommendations for monitoring and prevention, and suggestions for when a child should be considered a candidate for therapy.

Ward LM, Konji VN, & Ma J. Osteoporos Int 2016;27:2147–2179. doi:10.1007/s00198-016-3515-9


More on bone diseases


« Back to main page | Osteoporosis | Clinical trials | Diagnosis and screening | Epidemiology | Fracture | Lifestyle interventions | Medications | Pain | Pathophysiology | Prevention | Quality of life | Risk prediction


Image Credits